Gene expression and the biological phenotype of papillary thyroid carcinomas (original) (raw)
Kinase Expression and Chromosomal Rearrangements in Papillary Thyroid Cancer Tissues: Investigations at the Molecular and Microscopic Levels
Ulli Weier
2009
View PDFchevron_right
Heterogeneity in the Distribution of RET / PTC Rearrangements within Individual Post-Chernobyl Papillary Thyroid Carcinomas
Kristian Unger
The Journal of Clinical Endocrinology & Metabolism, 2004
View PDFchevron_right
Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers
Christopher e. Mason
Journal of Clinical Investigation, 2013
View PDFchevron_right
Chromosomal Rearrangements of RET/PTC in Post-Chernobyl Thyroid Cancer
Sergei Jargin
Multidisciplinary Cancer Investigation, 2020
View PDFchevron_right
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
Vitor Trovisco
Oncogene, 2003
View PDFchevron_right
BRAF Mutations Are Not a Major Event in Post Chernobyl Childhood Thyroid Carcinomas
Paula Soares
View PDFchevron_right
Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma
A. Sofiadis
European Journal of Endocrinology, 2012
View PDFchevron_right
Comparison of the Breakpoint Regions of ELE1 and RET Genes Involved in the Generation of RET/PTC3 Oncogene in Sporadic and in Radiation-Associated Papillary Thyroid Carcinomas
marco alessandro pierotti
Genomics, 1997
View PDFchevron_right
BRAF mutations are associated with some histological types of papillary thyroid carcinoma
Vitor Trovisco
The Journal of Pathology, 2004
View PDFchevron_right
RET/PTC3 rearrangements in Chernobyl-related thyroid cancer vs. late detection
Sergei Jargin
International Journal of Cancer Research and Molecular Mechanisms, 2015
View PDFchevron_right
Concomitant BRAF V600E Mutation and RET/PTC Rearrangement Is a Frequent Occurrence in Papillary Thyroid Carcinoma
DIANA MARCELA CHAPARRO RIVERA
View PDFchevron_right
Rearrangements of NTRK1 gene in papillary thyroid carcinoma
marco alessandro pierotti
Molecular and Cellular Endocrinology, 2010
View PDFchevron_right
Characterization of a novel rearrangement from the ret/PTC family in a case of radiation-associated human thyroid papillary carcinoma
Serik Meirmanov
International Congress Series, 2003
View PDFchevron_right
RET/PTC Rearrangements Preferentially Occurred in Papillary Thyroid Cancer among Atomic Bomb Survivors Exposed to High Radiation Dose
Wataru Yasui
Cancer Research, 2008
View PDFchevron_right
High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines
Kenneth Ain
Cancer research, 2003
View PDFchevron_right
Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications
C. Beimfohr
Clinical cancer research : an official journal of the American Association for Cancer Research, 2000
View PDFchevron_right
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma
L. Fugazzola
The Journal of Clinical Endocrinology & Metabolism, 1996
View PDFchevron_right
Xu X, Quiros RM, Gattuso P, et al. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines
Kenneth Ain
Cancer Research
View PDFchevron_right
Molecular defects in thyroid carcinomas: Role of the RET oncogene in thyroid neoplastic transformation
G. Vecchio
European Journal of Endocrinology, 1995
View PDFchevron_right
Anaplastic lymphoma kinase (ALK) gene rearrangements in radiation-related human papillary thyroid carcinoma after the Chernobyl accident
Alexis Rump
The journal of pathology. Clinical research, 2018
View PDFchevron_right
BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?
Sebastiano Filetti
Endocrine, 2014
View PDFchevron_right
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma
Carmen Monaco
The American journal of pathology, 2002
View PDFchevron_right
The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway
Jianwei Wang
Oncogene, 2000
View PDFchevron_right
RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations
Khurshid Andrabi
Pathology & Oncology Research, 2018
View PDFchevron_right
Thyrotropin signaling confers more aggressive features with higher genomic instability on BRAFV600E-induced thyroid tumors in a mouse model
Florence Orim
View PDFchevron_right
Major Oncogenic Drivers and Their Clinicopathological Correlations in Sporadic Childhood Papillary Thyroid Carcinoma in Belarus
Svetlana Mankovskaya
Cancers
View PDFchevron_right
Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer
marco alessandro pierotti
Oncogene, 2004
View PDFchevron_right
A Review of Driver Genetic Alterations in Thyroid Cancers
Fatemeh Khatami
Iranian Journal of Pathology
View PDFchevron_right
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma
Edna Kimura
Cancer research, 2003
View PDFchevron_right
Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident
L. Fugazzola
Cancer research, 1995
View PDFchevron_right
Molecular pathogenesis of pediatric thyroid carcinoma
Vladimir Saenko
Journal of Radiation Research
View PDFchevron_right